Which drugs should be avoided when taking lion’s mane (Hericium erinaceus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drug Interactions with Lion's Mane Mushroom

Lion's mane mushroom has no established contraindications with pharmaceutical medications based on current clinical guidelines, but theoretical concerns exist for patients taking anticoagulants, antiplatelet agents, antidiabetic medications, and immunosuppressants.

Medications Requiring Caution

Anticoagulants and Antiplatelet Agents

  • Monitor closely if taking warfarin, aspirin, clopidogrel, or other blood thinners, as mushroom polysaccharides may theoretically potentiate bleeding risk through platelet effects, similar to other medicinal mushrooms 1, 2
  • Check prothrombin time/INR more frequently when initiating lion's mane in patients on warfarin 1
  • Consider the additive bleeding risk if patient is already taking multiple antiplatelet herbs (ginkgo, garlic, ginger, turmeric) alongside lion's mane 2

Antidiabetic Medications

  • Exercise caution with insulin, sulfonylureas (glyburide, glimepiride), or other glucose-lowering agents, as lion's mane contains α-glucosidase inhibitory compounds that may enhance hypoglycemic effects 3
  • The erinacenols and hericenones in lion's mane demonstrate significant α-glucosidase inhibition (IC50 <20 μM), which could theoretically lower blood glucose additively with pharmaceutical agents 3
  • Monitor blood glucose more frequently when starting lion's mane, particularly in patients on tight glycemic control 1, 3
  • Consider dose reduction of antidiabetic medications if hypoglycemia occurs 1

Immunosuppressants

  • Use with caution in patients taking cyclosporine, tacrolimus, or other immunosuppressive therapy, as lion's mane has documented immunostimulating properties that could theoretically counteract immunosuppression 4
  • The β-glucan polysaccharides in lion's mane are responsible for immuno-modulating activity 5, 4
  • Monitor cyclosporine/tacrolimus levels if lion's mane is initiated, though no direct drug interaction via CYP450 metabolism has been documented 1

Antihypertensive Medications

  • Monitor blood pressure in patients taking antihypertensive medications, as lion's mane has reported anti-hypertensive properties that could theoretically cause additive blood pressure lowering 5, 4
  • This concern is theoretical rather than evidence-based, but warrants clinical vigilance 1

Medications with No Expected Interaction

Psychotropic Medications

  • No documented interactions exist between lion's mane and antidepressants (SSRIs, SNRIs, MAOIs), antipsychotics, or benzodiazepines 2, 6
  • Unlike St. John's wort, lion's mane does not induce CYP450 enzymes and does not cause serotonin syndrome 2, 6
  • The neuroprotective effects of lion's mane work through nerve growth factor stimulation, not serotonergic mechanisms 4, 7

Cardiovascular Medications

  • No documented interactions with statins, beta-blockers, calcium channel blockers, or ACE inhibitors 1
  • Unlike grapefruit juice, lion's mane does not inhibit CYP3A4 1

Antibiotics and Antivirals

  • No documented interactions with common antibiotics or antiviral medications 1
  • Lion's mane does not affect rifamycin metabolism, unlike many herbal supplements 1

Perioperative Considerations

  • No specific recommendation exists to discontinue lion's mane before surgery, unlike St. John's wort (2-week discontinuation) or kava (2-week discontinuation) 2, 6
  • The lack of documented sedative properties distinguishes lion's mane from valerian, kava, and ashwagandha 2
  • However, consider discontinuing 1-2 weeks preoperatively in patients with bleeding risk factors due to theoretical antiplatelet concerns 2

Quality Control Concerns

  • Lion's mane supplements are not FDA-regulated, meaning content and potency vary significantly between products 6
  • The distinction between fruiting body extracts and mycelium preparations is critical, as erinacines are found only in cultured mycelium while hericenones are in fruiting bodies 8
  • Typical culinary consumption involves up to 300g of fresh fruiting body, whereas supplements contain concentrated extracts (often 10:1 ratio) 7

Clinical Monitoring Recommendations

  • Obtain baseline complete blood count, comprehensive metabolic panel, and coagulation studies if patient has bleeding risk factors 1
  • Monitor fasting glucose in diabetic patients starting lion's mane 1, 3
  • Check blood pressure in hypertensive patients 1
  • Reassess medication list for potential additive effects rather than direct drug-drug interactions 1

Common Pitfalls to Avoid

  • Do not confuse lion's mane with St. John's wort—they have completely different interaction profiles 2, 6
  • Do not assume all medicinal mushrooms have identical properties—lion's mane lacks the hepatotoxicity concerns of some other mushroom species 8
  • Do not overlook the patient's total supplement regimen—multiple herbs with antiplatelet effects create cumulative bleeding risk 2
  • Do not rely on product labeling alone—verify the specific preparation (fruiting body vs. mycelium) and extraction ratio 8, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Herb Interactions with Lurasidone and Divalproex Acid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hericium erinaceus: an edible mushroom with medicinal values.

Journal of complementary & integrative medicine, 2013

Guideline

Interactions Between Ashwagandha and St. John's Wort

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague-Dawley rats.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.